Difference between revisions of "Sleeve gastrectomy"
Jump to navigation
Jump to search
(→HPG) |
|||
| Line 24: | Line 24: | ||
</pre> | </pre> | ||
=== | ===Helicobacter gastritis=== | ||
<pre> | <pre> | ||
Partial Stomach, Sleeve Gastrectomy: | Partial Stomach, Sleeve Gastrectomy: | ||
| Line 31: | Line 31: | ||
- NEGATIVE for intestinal metaplasia. | - NEGATIVE for intestinal metaplasia. | ||
- NEGATIVE for dysplasia and NEGATIVE for malignancy. | - NEGATIVE for dysplasia and NEGATIVE for malignancy. | ||
</pre> | |||
====Present on prior biopsy==== | |||
<pre> | |||
Comment: | |||
The prior stomach biopsy findings are noted. | |||
Please ensure this individual has gotten Helicobacter eradication therapy and re-assess as clinically indicated. | |||
</pre> | </pre> | ||
Revision as of 14:38, 2 May 2018
Sleeve gastrectomy is a surgical procedure to treat obesity. It is a common ditzel in GI pathology at centres that have obesity surgery.
General
- Indication: morbid obesity.
- The prevalence of Helicobacter gastritis is 33-44%.[1][2]
- GISTs are seen in 0.6% of cases (based on a series of 827 patients[3]).
Sign out
Normal
Partial Stomach, Sleeve Gastrectomy: - Stomach wall within normal limits.
IM
Partial Stomach, Sleeve Gastrectomy: - Stomach wall with a small quantity of INTESTINAL METAPLASIA and moderate (mucosa confined) chronic inactive inflammation. - Fundic gland polyp. - NEGATIVE for Helicobacter-like organisms. - NEGATIVE for dysplasia and NEGATIVE for malignancy.
Helicobacter gastritis
Partial Stomach, Sleeve Gastrectomy: - Stomach wall with abundant HELICOBACTER-LIKE ORGANISMS (mucosa) and moderate chronic active inflammation of the mucosa. - NEGATIVE for intestinal metaplasia. - NEGATIVE for dysplasia and NEGATIVE for malignancy.
Present on prior biopsy
Comment: The prior stomach biopsy findings are noted. Please ensure this individual has gotten Helicobacter eradication therapy and re-assess as clinically indicated.
Block letters
STOMACH, GREATER CURVE, SLEEVE GASTRECTOMY: - STOMACH WALL WITHIN NORMAL LIMITS.
See also
References
- ↑ Albawardi A, Almarzooqi S, Torab FC (2013). "Helicobacter pylori in sleeve gastrectomies: prevalence and rate of complications". Int J Clin Exp Med 6 (2): 140–3. PMC 3560499. PMID 23386918. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560499/.
- ↑ Onzi TR, d'Acampora AJ, de Araújo FM, et al. (March 2014). "Gastric histopathology in laparoscopic sleeve gastrectomy: pre- and post-operative comparison". Obes Surg 24 (3): 371–6. doi:10.1007/s11695-013-1107-8. PMID 24158738.
- ↑ Yuval, JB.; Khalaileh, A.; Abu-Gazala, M.; Shachar, Y.; Keidar, A.; Mintz, Y.; Nissan, A.; Elazary, R. (Jun 2014). "The True Incidence of Gastric GIST-a Study Based on Morbidly Obese Patients Undergoing Sleeve Gastrectomy.". Obes Surg. doi:10.1007/s11695-014-1336-5. PMID 24965544.